Functional annotation of rare gene aberration drivers of pancreatic cancer

Nature Communications

Volumn 7, Issue , 2016, Pages

  Tsang, Yiu Huen ^a   Dogruluk, Turgut ^a   Tedeschi, Philip M ^b   Wardwell Ozgo, Joanna ^a   Lu, Hengyu ^a   Espitia, Maribel ^c   Nair, Nikitha ^a   Minelli, Rosalba ^a   Chong, Zechen ^c   Chen, Fengju ^a   Chang, Qing Edward ^c   Dennison, Jennifer B ^c   Dogruluk, Armel ^a   Li, Min ^d   Ying, Haoqiang ^c   Bertino, Joseph R ^b   Gingras, Marie Claude ^a   Ittmann, Michael ^a   Kerrigan, John ^b   Chen, Ken ^c   Creighton, Chad J ^a   Eterovic, Karina ^c   Mills, Gordon B ^c   Scott, Kenneth L ^a   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE KINASE; REACTIVE OXYGEN METABOLITE; PHOSPHOTRANSFERASE;

CANCER; ENZYME ACTIVITY; GENE EXPRESSION; GENOME; MEDICINE; MUTATION; OXYGEN; REACTION KINETICS; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; DNA BARCODING; FEMALE; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS ADENOCARCINOMA; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; TUMOR GENE; ANIMAL; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MUTATION; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; FEMALE; HUMANS; MICE; MICE, NUDE; MUTATION; PANCREATIC NEOPLASMS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REACTIVE OXYGEN SPECIES;

EID: 84955444058     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10500     Document Type: Article

References (56)

1. Moody, S. E., Boehm, J. S., Barbie, D. A. & Hahn, W. C. Functional genomics and cancer drug target discovery. Curr. Opin. Mol. Ther. 12, 284-293 (2010).
2. Mohr, S. E., Smith, J. A., Shamu, C. E., Neumuller, R. A. & Perrimon, N. RNAi screening comes of age: improved techniques and complementary approaches. Nat. Rev. Mol. Cell Biol. 15, 591-600 (2014).
3. Dunn, G. P. et al. In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene. Proc. Natl Acad. Sci. USA 111, 1102-1107 (2014).
4. Wang, Y. et al. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. eLife 3, e01763 (2014).
5. Johannessen, C. M. et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 504, 138-142 (2013).
6. Shrestha, Y. et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 31, 3397-3408 (2012).
7. Boehm, J. S. et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129, 1065-1079 (2007).
8. Pavlova, N. N. et al. A role for PVRL4-driven cell-cell interactions in tumorigenesis. eLife 2, e00358 (2013).
9. Rual, J. F. et al. Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res. 14, 2128-2135 (2004).
10. Lamesch, P. et al. hORFeome v3.1: a resource of human open reading frames representing over 10 000 human genes. Genomics 89, 307-315 (2007).
11. Yang, X. et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 8, 659-661 (2011).
12. Temple, G. et al. The completion of the Mammalian Gene Collection (MGC). Genome Res. 19, 2324-2333 (2009).
13. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
14. Wu, W., Jia, Z., Liu, P., Xie, Z. & Wei, Q. A novel PCR strategy for high-efficiency, automated site-directed mutagenesis. Nucleic Acids Res. 33, e110 (2005).
15. Furukawa, T. et al. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am. J. Pathol. 148, 1763-1770 (1996).
16. Ouyang, H. et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am. J. Pathol. 157, 1623-1631 (2000).
17. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463-2479 (2010).
18. Singh, A. et al. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 15, 489-500 (2009).
19. Pollak, N., Dolle, C. & Ziegler, M. The power to reduce: pyridine nucleotides - small molecules with a multitude of functions. Biochem. J. 402, 205-218 (2007).
20. Sousa, C. M. & Kimmelman, A. C. The complex landscape of pancreatic cancer metabolism. Carcinogenesis 35, 1441-1450 (2014).
21. Wang, H. et al. Crystal structure of human NAD kinase. RCSB PDB (2011).
22. Rod, T. H., Radkiewicz, J. L. & Brooks, 3rd C. L. Correlated motion and the effect of distal mutations in dihydrofolate reductase. Proc. Natl Acad. Sci. USA 100, 6980-6985 (2003).
23. Meerbrey, K. L. et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 3665-3670 (2011).
24. Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101-105 (2013).
25. Kong, B., Qia, C., Erkan, M., Kleeff, J. & Michalski, C. W. Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels. Front. Physiol. 4, 246 (2013).
26. Hsieh, Y. C. et al. Enhanced degradation of dihydrofolate reductase through inhibition of NAD kinase by nicotinamide analogs. Mol. Pharmacol. 83, 339-353 (2013).
27. Fruehauf, J. P. & Meyskens, Jr F. L. Reactive oxygen species: a breath of life or death? Clin. Cancer Res. 13, 789-794 (2007).
28. Cui, X. Reactive oxygen species: the achilles' heel of cancer cells? Antioxid. Redox Signal. 16, 1212-1214 (2012).
29. Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic. Res. 44, 479-496 (2010).
30. Pineda, C. T. et al. Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell 160, 715-728 (2015).
31. Liu, W., Cheng, S., Asa, S. L. & Ezzat, S. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res. 68, 8104-8112 (2008).
32. Hirata, Y. et al. ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett. 356, 244-248 (1994).
33. Kajimoto, Y. et al. Pancreatic islet cells express BST-1, a CD38-like surface molecule having ADP-ribosyl cyclase activity. Biochem. Biophys. Res. Commun. 219, 941-946 (1996).
34. Lee, H. C. Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization. J. Biol. Chem. 287, 31633-31640 (2012).
35. Lo Buono, N. et al. The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes. J. Biol. Chem. 286, 18681-18691 (2011).
36. Ortolan, E. et al. Functional role and prognostic significance of CD157 in ovarian carcinoma. J. Natl Cancer Inst. 102, 1160-1177 (2010).
37. Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450 (2003).
38. Creighton, C. J., Nagaraja, A. K., Hanash, S. M., Matzuk, M. M. & Gunaratne, P. H. A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 14, 2290-2296 (2008).
39. Kammann, M., Laufs, J., Schell, J. & Gronenborn, B. Rapid insertional mutagenesis of DNA by polymerase chain reaction (PCR). Nucleic Acids Res. 17, 5404 (1989).
40. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
41. Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
42. Dunbrack, Jr R. L. Rotamer libraries in the 21st century. Curr. Opin. Struct. Biol. 12, 431-440 (2002).
43. Liu, J. et al. Crystal structures of an NAD kinase from Archaeoglobus fulgidus in complex with ATP, NAD, or NADP. J. Mol. Biol. 354, 289-303 (2005).
44. Guex, N. & Peitsch, M. C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723 (1997).
45. Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845-854 (2013).
46. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950-1958 (2010).
47. Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157-1174 (2004).
48. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935 (1983).
49. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an Nṡlog(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092 (1993).
50. Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577-8593 (1995).
51. Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463-1472 (1997).
52. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).
53. Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182-7190 (1981).
54. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037-10041 (2001).
55. Lerner, F., Niere, M., Ludwig, A. & Ziegler, M. Structural and functional characterization of human NAD kinase. Biochem. Biophys. Res. Commun. 288, 69-74 (2001).
56. Michaelis, L. & Menten, M. M. The kinetics of invertin action. 1913. FEBS Lett. 587, 2712-2720 (2013).